The Valley Desk

NCT02316002 · Interventional trial

Phase II Study of Pembrolizumab After Curative Intent Treatment for Oligometastatic Non-Small Cell Lung Cancer

Overall registry status Completed

Phase 2

Conditions Oligometastatic Non-small Cell Lung Cancer (NSCLC)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov